3D Systems Dirección

Dirección controles de criterios 3/4

3D Systems' El consejero delegado es Jeff Graves , nombrado en May 2020, tiene un mandato de 3.75 años. la remuneración anual total es $5.69M , compuesta por 14.9% salario y 85.1% primas, incluidas acciones y opciones de la empresa. posee directamente 0.62% de las acciones de la empresa, por valor de CHF3.80M . La antigüedad media del equipo directivo y del consejo de administración es de 2.5 años y 6.7 años respectivamente.

Información clave

Jeff Graves

Chief Executive Officer (CEO)

US$5.7m

Compensación total

Porcentaje del salario del CEO	14.9%
Permanencia del CEO	3.9yrs
Participación del CEO	0.6%
Permanencia media de la dirección	2.7yrs
Promedio de permanencia en la Junta Directiva	6.8yrs

Actualizaciones recientes de la dirección

Recent updates

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Jeff Graves en comparación con los beneficios de 3D Systems?
Fecha	Compensación total	Salario	Ingresos de la empresa
Dec 31 2023	n/a	n/a	-US$370m
Sep 30 2023	n/a	n/a	-US$96m
Jun 30 2023	n/a	n/a	-US$122m
Mar 31 2023	n/a	n/a	-US$126m
Dec 31 2022	US$6m	US$850k	-US$123m
Sep 30 2022	n/a	n/a	-US$104m
Jun 30 2022	n/a	n/a	US$227m
Mar 31 2022	n/a	n/a	US$250m
Dec 31 2021	US$9m	US$837k	US$322m
Sep 30 2021	n/a	n/a	US$308m
Jun 30 2021	n/a	n/a	-US$57m
Mar 31 2021	n/a	n/a	-US$85m
Dec 31 2020	US$6m	US$489k	-US$150m

Compensación vs. Mercado: Jeff($USD5.69M) está por encima de la media de empresas de tamaño similar en el mercado Swiss ($USD1.25M).

Compensación vs. Ingresos: La compensación de Jeff ha sido consistente con los resultados de la empresa en el último año.

CEO

Jeff Graves (62 yo)

3.9yrs

Permanencia

US$5,687,162

Compensación

Dr. Jeffrey Alan Graves, also known as Jeff, is Independent Director of Integra LifeSciences Holdings Corporation from December 12, 2023. Dr. Graves is President, CEO & Director of 3D Systems Corporation f...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Jeffrey Graves	President	3.9yrs	US$5.69m	0.61% $ 2.9m
Reji Puthenveetil	Executive Vice President of Industrial Solutions & Chief Commercial Officer	3.8yrs	US$2.17m	0.21% $ 996.7k
Andrew Johnson	Executive VP	12yrs	US$1.73m	0.17% $ 814.4k
Menno Ellis	Executive officer	3.8yrs	US$2.11m	0.18% $ 842.1k
Charles Hull	Co-Founder	no data	sin datos	0.40% $ 1.9m
Jeffrey Creech	Executive VP & CFO	less than a year	sin datos	0.071% $ 339.3k
Joseph Zuiker	Executive Vice President of Engineering & Operations	1.3yrs	sin datos	0.068% $ 326.2k
Margaret Wicklund	Senior VP	less than a year	sin datos	0.036% $ 173.9k
Phyllis Nordstrom	Executive VP	2.7yrs	sin datos	0.071% $ 339.9k
Michael McCloskey	Treasurer & VP of Investor Relations	no data	sin datos	sin datos
Harriss Currie	President - Regenerative Medicine	less than a year	sin datos	0.096% $ 459.4k

2.7yrs

Permanencia media

58yo

Promedio de edad

Equipo directivo experimentado: DDDEl equipo directivo de la empresa se considera experimentado (3.4 años de antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Jeffrey Graves	President	4.3yrs	US$5.69m	0.61% $ 2.9m
Charles Hull	Co-Founder	no data	sin datos	0.40% $ 1.9m
Jim Kever	Independent Director	28.3yrs	US$220.00k	0.32% $ 1.5m
Thomas Erickson	Independent Director	8.4yrs	US$220.00k	0.19% $ 922.0k
Kevin Moore	Independent Director	24.5yrs	US$245.00k	0.13% $ 643.4k
Charles McClure	Independent Chairman of the Board	7.1yrs	US$400.00k	0.067% $ 322.4k
William Curran	Independent Director	16.3yrs	US$255.00k	0.11% $ 510.6k
John Tracy	Independent Director	6.8yrs	US$240.00k	0.066% $ 317.3k
Stephen Klasko	Chair of Medical Advisory Board	1.9yrs	sin datos	sin datos
Malissia Clinton	Independent Director	5.1yrs	US$225.00k	0.047% $ 225.0k
Vasant Padmanabhan	Independent Director	3.3yrs	US$210.00k	0.041% $ 197.2k
Claudia Drayton	Independent Director	2.3yrs	US$215.00k	0.027% $ 130.8k

6.8yrs

Permanencia media

69yo

Promedio de edad

Junta con experiencia: La junta directiva de DDD se considera experimentada (6.5 años de antigüedad promedio).

3D Systems Dirección

Dirección controles de criterios 3/4

Información clave

Actualizaciones recientes de la dirección

3D Systems Corporation Announces Executive Changes

3D Systems Corporation Appoints Andrew Johnson as Interim Chief Financial Officer

3D Systems Appoints Jeffrey Creech as Chief Financial Officer

Independent Director recently bought CHF202k worth of stock

Systems Corporation Appoints Margaret E. Wicklund as Senior Vice President and Chief Accounting Officer

3D Systems Corporation Announces CFO Changes

Recent updates

3D Systems Receives NYSE Notice Regarding Late Form 10-K Filing

3D Systems Corporation announced delayed annual 10-K filing

New minor risk - Profitability

3D Systems Corporation Provides Earnings Guidance for the Full-Year of 2024

Full year 2023 earnings released: US$2.85 loss per share (vs US$0.96 loss in FY 2022)

3D Systems Corporation Reports Unaudited Consolidated Impairment Charges Results for the Fourth Quarter Ended December 31, 2023

3D Systems Introduces First Multi-Material, One-Piece Jetted Denture Solution

3D Systems Corporation to Report Q4, 2023 Results on Feb 27, 2024

3D Systems Corporation Announces Executive Changes

3D Systems Corporation Appoints Andrew Johnson as Interim Chief Financial Officer

3D Systems Appoints Jeffrey Creech as Chief Financial Officer

Independent Director recently bought CHF202k worth of stock

Third quarter 2023 earnings released: US$0.09 loss per share (vs US$0.30 loss in 3Q 2022)

3D Systems Corporation to Report Q3, 2023 Results on Nov 08, 2023

Systems Corporation Appoints Margaret E. Wicklund as Senior Vice President and Chief Accounting Officer

3D Systems Corporation Announces CFO Changes

the Rosen Law Firm, P.A. Announces Proposed Class Action Settlement on Behalf of Purchasers of 3D Systems Corporation Publicly-Traded Common Stock

3D Systems Corporation Revises Earnings Guidance for the Full Year 2023

Second quarter 2023 earnings released: US$0.22 loss per share (vs US$0.26 loss in 2Q 2022)

3D Systems Corporation to Report Q2, 2023 Results on Aug 09, 2023

3D Systems Introduces New Materials Engineered to Expand Capabilities of SLA and Figure 4 Platforms

New minor risk - Shareholder dilution

Insider recently sold CHF135k worth of stock

3D Systems Corporation (NYSE:DDD) submitted a non-binding proposal to acquire Stratasys Ltd. (NasdaqGS:SSYS) for $1.3 billion.

Independent Director recently sold CHF67k worth of stock

3D Systems Corporation Provides Earnings Guidance for the Year 2023

First quarter 2023 earnings released: US$0.23 loss per share (vs US$0.21 loss in 1Q 2022)

Full year 2022 earnings released: US$0.96 loss per share (vs US$2.62 profit in FY 2021)

3D Systems Introduces ProJet MJP 2500W Plus — New 3D Printing Solution for Jewelry Manufacturing Dramatically Improves Productivity

3D Systems Appoints Dr. Rebekah Gee as Member of Its Medical Advisory Board, Effective March 1, 2023

3D Systems Corporation to Report Q4, 2022 Results on Feb 28, 2023

rms Company Scales Medical Device Production with Addition of 3D Systems’ DMP Flex 350 Dual

3D Systems Appoints Bert Bruce to its Medical Advisory Board

Executive VP recently sold CHF68k worth of stock

3D Systems Announces Management Appointments

President recently bought CHF182k worth of stock

High number of new directors

3D Systems Corporation Revises Earnings Guidance for the Fiscal Year 2022

3D Systems Corporation to Report Q3, 2022 Results on Nov 08, 2022

3D Systems Corporation Announces Appointment of Andrew Johnson as Chief Corporate Development Officer

Executive VP recently sold CHF65k worth of stock

3D Systems Corporation Appoints Taci Pereira as Systemic Bio’s Chief Executive Officer

3D Systems Announces First to Market Cuni (Cuni30) Alloy for Laser Powder Bed Fusion

3D Systems Corporation Announces Executive Changes

3D Systems Announces Board Changes

Second quarter 2022 earnings released: US$0.26 loss per share (vs US$0.079 loss in 2Q 2021)

3D Systems Corporation (NYSE:DDD) agreed to acquire dp polar GmbH from Hans Mathea.

3D Systems Announces Appointment of the Honorable Alex M. Azar II to Its Medical Advisory Board

3D Systems Appoints Michael Turner as Executive Vice President, Effective August 29, 2022

High number of new directors

3D Systems Corporation to Report Q2, 2022 Results on Aug 08, 2022

High number of new directors

Co-Founder recently sold CHF282k worth of stock

3D Systems Corporation Announces Appointment of David J. Shulkin to Medical Advisory Board

President recently bought CHF103k worth of stock

3D Systems Announces Establishment of Medical Advisory Board & Appointment of Stephen K. Klasko as Chair

First quarter 2022 earnings released: US$0.21 loss per share (vs US$0.37 profit in 1Q 2021)

3D Systems Corporation Revises Earnings Guidance for the Full Year 2022

3D Systems Announces Revenue Guidance for 2022

3D Systems Corporation Announces Vsp® Bolus to Optimize Radiotherapy Targeting, Improve Patient Experience

3D Systems Corporation to Report Q1, 2022 Results on May 09, 2022

3D Systems Corporation, Annual General Meeting, May 24, 2022

3D Systems Introduces SLA 750 – the Fastest Stereolithography Printer

President recently sold CHF558k worth of stock

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

3D Systems Corporation Provides Earnings Guidance for the Year 2022

3D Systems Corporation (NYSE:DDD) acquired Titan Robotics, Ltd.

3D Systems Corporation (NYSE:DDD) agreed to acquire KUMOVIS GmbH from High-Tech GrÜNderfonds Management Gmbh, Solvay Ventures, Renolit SE and others.

3D Systems Corporation to Report Q4, 2021 Results on Feb 28, 2022